广州白云山医药集团股份有限公司关于附属企业参与投资设立广州荔湾 广药创业投资基金合伙企业(有限合伙)暨关联交易的进展公告

Group 1 - The company has approved the establishment of the Guangzhou Liwan Guangyao Venture Capital Fund Partnership (Limited Partnership) through its subsidiary, Guangzhou Guangyao Phase II Fund Equity Investment Partnership (Limited Partnership) [1] - The partnership involves collaboration with Guangzhou Guangyao Capital Private Fund Management Co., Ltd., Guangzhou Angel Investment Mother Fund Venture Capital Partnership (Limited Partnership), and Guangzhou Liwan District Industrial Investment Fund Partnership (Limited Partnership) [1] - The partnership agreement has been signed recently, with no changes to the main content compared to the previous announcement [2] Group 2 - The establishment of the Guangzhou Liwan Guangyao Fund is pending necessary registration and filing procedures, which introduces some uncertainties in the implementation process [2] - The company will continue to monitor the progress of this investment and fulfill its information disclosure obligations in accordance with relevant laws and regulations [2]